ScreenPro Security Inc. wishes to update shareholders on inquiries that the Company has received on consolidation of the issued and outstanding common shares of the Company .As voted on at the last Annual General and Special Meeting of shareholders, a special resolution was approved on a consolidation of the Company's Common Shares up to one new share for fifteen old shares. At this point in time, the Company does ...

ScreenPro Security Inc. (CSE: SCRN) ("ScreenPro" or the "Company") wishes to update shareholders on inquiries that the Company has received on consolidation of the issued and outstanding common shares of the Company (the "Common Shares").

As voted on at the last Annual General and Special Meeting (the"Meeting") of shareholders, a special resolution was approved on a consolidation of the Company's Common Shares up to one (1) new share for fifteen (15) old shares. At this point in time, the Company does not intend to proceed with the share consolidation of the Company.

The Company also wishes announce that it has decided not to proceed on any further bidding with the UK's National Health Service (NHS) with Enoura Medical in the United Kingdom (UK). ScreenPro will be focusing on its operations in Canada as a deep and narrow strategy.

Lena Kozovski, CEO of ScreenPro Security, commented, "As CEO of the Company, I am committed to create shareholder value and earn the support of our customers, our valued shareholders, and employees in the regions in which we operate. ScreenPro is a young company with excellent prospects ahead, and you have my commitment to provide responsible management, our obligation to our shareholders, and our responsibility to build a strong, valuable and sustainable business."

About ScreenPro

ScreenPro是筛选和医疗科技有限公司mpany that provides turnkey screening solutions with its proprietary medical alerting software. ScreenPro's unique access to multiple manufacturers of high-quality test kits and its strategic partnership with labs in British Columbia, Ontario and Quebec allowing ScreenPro to be a full-service nationwide provider of COVID testing solutions across Canada. In addition, ScreenPro has its own medical doctor and nursing professionals along with on the ground support staff and transportation, as access to high quality PPEs to ensure that its clients are protected in all aspects of their testing needs. ScreenPro provides alerting software through its secure GoStop application that enables individuals to use the app for test screening results as well as provides automated identification codes for our laboratories and analytics to our clients on their testing cadence. For additional information on ScreenPro and other corporate information, please visit the Company's website atwww.screenprosecurity.com.

For more information about the Company, please refer to the Company's profile on SEDAR atwww.sedar.com.

Neither the Canadian Securities Exchange (the "CSE") nor it's Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

For further information please contact:

Jamie Hyland, Director
Email:info@screenprosecurity.com
P. (604) 442-2425

Forward-Looking Statements:

Certain statements contained in this news release may constitute forward‐looking information, including statements relating to expectations regarding the future development of ScreenPro's business. Forward‐looking information is often, but not always, identified by the use of words such as "anticipate", "plan", "estimate", "expect", "may", "will", "intend", "should", and similar expressions. Forward‐looking information involves known and unknown risks, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward‐looking information. The actual results of ScreenPro could differ materially from those anticipated in this forward‐looking information as a result of regulatory decisions, competitive factors in the industries in which ScreenPro operates, prevailing economic conditions, changes to ScreenPro's strategic growth plans, and other factors, many of which are beyond the control of ScreenPro. Management of ScreenPro believes that the expectations reflected in the forward‐looking information herein are reasonable, but no assurance can be given that these expectations will prove to be correct and such forward‐looking information should not be unduly relied upon. Any forward‐looking information contained in this news release represents ScreenPro's expectations as of the date hereof and is subject to change after such date. ScreenPro disclaims any intention or obligation to update or revise any forward‐looking information whether as a result of new information, future events or otherwise, except as required by applicable securities legislation.

###

To view the source version of this press release, please visithttps://www.newsfilecorp.com/release/101200

News Provided by Newsfile via QuoteMedia

ScreenPro Building Cash Position With Continued Growth In Covid Testing Numbers

ScreenPro Building Cash Position With Continued Growth In Covid Testing Numbers

ScreenPro Security Inc. (CSE: SCRN) (OTCQB: SCRSF) ("ScreenPro" or the "Company") is pleased to report a significant increase in the Covid-19 testing numbers this year, which attributes to the Company's stronger cash position. Covid testing remains in high demand for the film and production industry. Due to the nature of the work environment, staff members are often operating in contained areas and in close proximity. With various highly contagious variants, such as Omicron and the numbers of infections increasing, we foresee more contracts throughout 2022.

The Company also faces a rise in demand for testing in the travel and tourism industry along with its concierge (home/office visit) services. In addition to thenews release on March 24th, 2022, the Company has received three additional testing contracts in television and production dated as of April 8, 2022, resulting in a total of 21 new productions to date for Q1 of FY22.

News Provided by Newsfile via QuoteMedia

Keep reading... Show less
ScreenPro Insiders Acquire Additional Shares

ScreenPro Insiders Acquire Additional Shares

ScreenPro Security Inc. (CSE: SCRN) (OTCQB: SCRSF) ("ScreenPro" or the "Company") is pleased to report that further to the press release on April 4, 2022, certain members of the Board of Directors and Senior Management have further increased their positions in the Company by purchasing additional shares in open-market transactions between April 5, 2022, and April 6, 2022, for an additional 1,680,000. Details of the purchase is as follows:

  • Michael Yeung, Chairman, purchased 435,000 shares at an average price of $0.068
  • 莉娜Kozovski,首席执行官,395年购买的,000 shares at an average price of $0.07
  • Paul Haber, CFO, purchased 400,000 shares at an average price of $0.07
  • Youngcho Lee, Director, purchased 450,000 shares at an average price of $0.067

Over the past two weeks, certain members of the Board of Directors and Senior Management accumulated a total of 4,521,000,representing 6.1% of the total outstanding sharesof 74,638,916.

News Provided by Newsfile via QuoteMedia

Keep reading... Show less
ScreenPro Announces Insider Purchases of Shares

ScreenPro Announces Insider Purchases of Shares

ScreenPro Security Inc. (CSE: SCRN) (OTCQB: SCRSF) ("ScreenPro" or the "Company") is pleased to report that certain members of the Board of Directors and Senior Management have purchased 2,841,600 shares of the Company between March 29, 2022, to March 31, 2022, in open-market transactions. Details of the purchase is as follows:

Michael Yeung, Chairman, purchased 660,000 shares at an average price of $0.075

News Provided by Newsfile via QuoteMedia

Keep reading... Show less
Add Biomedical Submits Application to USPTO for Rapid Breast Cancer Screening

Add Biomedical Submits Application to USPTO for Rapid Breast Cancer Screening

ScreenPro Security Inc. (CSE: SCRN) (OTCQB: SCRSF) ("ScreenPro" or the "Company") is pleased to announce that the Company's wholly owned subsidiary, Add Biomedical Inc. (Add Bio), is strengthening its library of intellectual property (IP). The Company has applied for the Cancer Antigen (CA) 15-3 rapid testing kit for breast cancer screening to the United States Patent and Trademark Office (USPTO).

Breast cancer is the world's most commonly occurring cancer. According to Cancer.ca, breast cancer is the second leading cause of cancer deaths in Canadian women. Recent reports show that 76 Canadian women are diagnosed with breast cancer everyday and on average, 15 of those women die from the disease everyday. (Source:Canadian Cancer Society)

News Provided by Newsfile via QuoteMedia

Keep reading... Show less
ScreenPro Continues to Increase Market Share in Covid Testing

ScreenPro Continues to Increase Market Share in Covid Testing

ScreenPro Security Inc. (CSE: SCRN) (OTCQB: SCRSF) ("ScreenPro" or the "Company") is pleased to announce that further to the press release of March 21st, 2022, the Company has received seven (7) additional Covid testing contracts from prominent companies in the North American film industry.

Although there have been several changes in the current Covid climate with restrictions being lifted, the virus is still present, making Covid testing crucial in the film and production industry. The Company is showing tremendous growth within this sector with various productions that are scheduled to begin testing over the next two months. The Company anticipates that the current levels of testing will last substantial time.

News Provided by Newsfile via QuoteMedia

Keep reading... Show less
ScreenPro Announces Growth in Covid Testing

ScreenPro Announces Growth in Covid Testing

ScreenPro Security Inc. (CSE: SCRN) (OTCQB: SCRSD) ("ScreenPro" or the "Company") is pleased to announce that further to its press release of February 25th, 2022, the Company has received four (4) additional Covid testing contracts from well-know film production companies in Vancouver and Toronto.

Though the Covid environment is changing, testing is strong with a 50% increase in added productions compared to February and over 20% in weekly growth this month. The Company is now providing testing for a total of eleven (11) film production companies.

News Provided by Newsfile via QuoteMedia

Keep reading... Show less
×